KR102464821B9 - 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물 - Google Patents

목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물

Info

Publication number
KR102464821B9
KR102464821B9 KR1020220045772A KR20220045772A KR102464821B9 KR 102464821 B9 KR102464821 B9 KR 102464821B9 KR 1020220045772 A KR1020220045772 A KR 1020220045772A KR 20220045772 A KR20220045772 A KR 20220045772A KR 102464821 B9 KR102464821 B9 KR 102464821B9
Authority
KR
South Korea
Prior art keywords
sustained
same
moxidectin
injection composition
release injection
Prior art date
Application number
KR1020220045772A
Other languages
English (en)
Other versions
KR102464821B1 (ko
Inventor
김주희
이상노
Original Assignee
(주)인벤티지랩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)인벤티지랩 filed Critical (주)인벤티지랩
Priority to KR1020220045772A priority Critical patent/KR102464821B1/ko
Priority to PCT/KR2022/005968 priority patent/WO2023200035A1/ko
Application granted granted Critical
Publication of KR102464821B1 publication Critical patent/KR102464821B1/ko
Publication of KR102464821B9 publication Critical patent/KR102464821B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Dermatology (AREA)
KR1020220045772A 2022-04-13 2022-04-13 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물 KR102464821B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020220045772A KR102464821B1 (ko) 2022-04-13 2022-04-13 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물
PCT/KR2022/005968 WO2023200035A1 (ko) 2022-04-13 2022-04-27 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020220045772A KR102464821B1 (ko) 2022-04-13 2022-04-13 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물

Publications (2)

Publication Number Publication Date
KR102464821B1 KR102464821B1 (ko) 2022-11-09
KR102464821B9 true KR102464821B9 (ko) 2023-09-19

Family

ID=84040356

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220045772A KR102464821B1 (ko) 2022-04-13 2022-04-13 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물

Country Status (2)

Country Link
KR (1) KR102464821B1 (ko)
WO (1) WO2023200035A1 (ko)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100544732B1 (ko) 2004-07-13 2006-01-24 (주)이엘티사이언스 개 심장사상충 예방 및 박멸을 위한 경구용 이버멕틴페이스트 복합조성물 및 그의 제조방법
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US8946277B2 (en) * 2008-04-18 2015-02-03 Warsaw Orthopedic, Inc. Clonidine formulations in a biodegradable polymer carrier
CN102985175B (zh) * 2009-12-22 2016-03-09 赢创有限公司 用于制备微粒的基于乳液的工艺以及供所述工艺使用的工作头组件
WO2019050259A1 (ko) * 2017-09-06 2019-03-14 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
KR20220032301A (ko) * 2020-09-07 2022-03-15 (주)인벤티지랩 약물의 지속 방출을 위한 서방형 마이크로입자

Also Published As

Publication number Publication date
WO2023200035A1 (ko) 2023-10-19
KR102464821B1 (ko) 2022-11-09

Similar Documents

Publication Publication Date Title
IL289925A (en) Consequences of adenosine and a pharmaceutical preparation containing it
EP1679058A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ANGIOCARDIOPATHY
EP3967695A4 (en) QUINAZOLINE COMPOUND AND ITS PHARMACEUTICAL APPLICATION
EP3782998A4 (en) SUBSTITUTED PYRROLOTRIAZINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND THEIR USES
EP4233844A4 (en) SUSTAINED RELEASE COMPOSITION OF COMBINATION OF NALTREXONE AND RISPERIDONE
EP4005591A4 (en) ANTINEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION
IL287628A (en) Injectable pharmaceutical compounds and their uses
ZA202108300B (en) Sustained-release microparticles containing deslorelin, and preparation method therefor
EP4223759A4 (en) PYRAZOLOPYRIDAZINONE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE
KR102464821B9 (ko) 목시덱틴을 포함하는 마이크로 입자 및 이를 포함하는 서방형 주사제 조성물
IL282950A (en) Antibiotic compounds, methods for their production, pharmaceutical preparations containing them and their uses
IL284927A (en) Rogartinib hydrochloride monohydrate and solid forms thereof
PL3979827T3 (pl) Kompozycja żywieniowa zawierająca 2'fukozylolaktozę i 3'galaktozylolaktozę
IL304366A (en) Consequences of adenosine and a pharmaceutical preparation containing it
EP3805210A4 (en) NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
GB201906147D0 (en) Endothermic article and composition thereof
IL311162A (en) A tricyclic compound containing nitrogen and its pharmaceutical use
EP4180040A4 (en) PHARMACEUTICAL COMPOSITION AND ITS APPLICATION
EP4238966A4 (en) TETRAHYDRONAPHTHALIN COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
IL286073A (en) Syringe for drug mixing kit, drug mixing kit and method for its manufacture
EP4074304A4 (en) PHARMACEUTICAL COMPOSITION OF FULVESTRANT, PREPARATION METHOD AND APPLICATION THEREOF
EP4065598A4 (en) BIOTIN UNIT-CONJUGATED POLYPEPTIDES AND PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THEREOF
ES2969360T3 (es) Resina de policarbonato, método para producir la misma, composición de resina de policarbonato y cuerpo moldeado
EP4069278A4 (en) METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TYPE 1 DIABETES
SG11202104371XA (en) 1,3,4-oxadiazolone compound and pharmaceutical

Legal Events

Date Code Title Description
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]